DOI: 10.1096/fj.202201777rrr ISSN:

Activation of the inflammasome drives peritoneal deterioration in a mouse model of peritoneal fibrosis

Hiroyuki Kadoya, Akira Hirano, Reina Umeno, Eriko Kajimoto, Tsukasa Iwakura, Megumi Kondo, Yoshihisa Wada, Kengo Kidokoro, Seiji Kishi, Hajime Nagasu, Tamaki Sasaki, Shun’ichiro Taniguchi, Masafumi Takahashi, Naoki Kashihara
  • Genetics
  • Molecular Biology
  • Biochemistry
  • Biotechnology


During peritoneal dialysis (PD), the peritoneum is exposed to a bioincompatible dialysate, deteriorating the tissue and limiting the long‐term effectiveness of PD. Peritoneal fibrosis is triggered by chronic inflammation induced by a variety of stimuli, including peritonitis. Exposure to PD fluid alters peritoneal macrophages phenotype. Inflammasome activation triggers chronic inflammation. First, it was determined whether inflammasome activation causes peritoneal deterioration. In the in vivo experiments, the increased expression of the inflammasome components, caspase‐1 activity, and concomitant overproduction of IL‐1β and IL‐18 were observed in a mouse model of peritoneal fibrosis. ASC‐positive and F4/80‐positive cells colocalized in the subperitoneal mesothelial cell layer. These macrophages expressed high CD44 levels indicating that the CD44‐positive macrophages contribute to developing peritoneal deterioration. Furthermore, intravital imaging of the peritoneal microvasculature demonstrated that the circulating CD44‐positive leukocytes may contribute to peritoneal fibrosis. Bone marrow transplantation in ASC‐deficient mice suppressed inflammasome activation, thereby attenuating peritoneal fibrosis in a high glucose‐based PD solution‐injected mouse model. Our results suggest inflammasome activation in CD44‐positive macrophages may be involved in developing peritoneal fibrosis. The inflammasome‐derived pro‐inflammatory cytokines might therefore serve as new biomarkers for developing encapsulating peritoneal sclerosis.

More from our Archive